0000880984-22-000017.txt : 20221201 0000880984-22-000017.hdr.sgml : 20221201 20221201192911 ACCESSION NUMBER: 0000880984-22-000017 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221129 FILED AS OF DATE: 20221201 DATE AS OF CHANGE: 20221201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Javitt Daniel C. CENTRAL INDEX KEY: 0001864534 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38302 FILM NUMBER: 221439965 MAIL ADDRESS: STREET 1: 1201 NORTH MARKET STREET STREET 2: SUITE 111 CITY: WILMINGTON STATE: DE ZIP: 19801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NRX Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001719406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 822844431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1201 ORANGE STREET STREET 2: SUITE 600 CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 484-254-6134 MAIL ADDRESS: STREET 1: 1201 ORANGE STREET STREET 2: SUITE 600 CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Big Rock Partners Acquisition Corp. DATE OF NAME CHANGE: 20171012 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2022-11-29 0 0001719406 NRX Pharmaceuticals, Inc. NRXP 0001864534 Javitt Daniel C. 1201 NORTH MARKET STREET SUITE 111 WILMINGTON DE 19801 0 0 1 0 common stock 2022-11-29 4 S 0 13730 1.5041 D 9643234 I by Glytech LLC common stock 2022-11-30 4 S 0 8441 1.5046 D 9634793 I by Glytech LLC Sale was pursuant to the terms of a 10b5-1 trading plan established on June 13, 2022. Held by Glytech LLC of which the Reporting Person is the sole owner. Daniel Javitt 2022-12-01